{"title":"在全国范围内接受化疗的 III 期 NSCLC 患者中,PD-L1 评分与杜伐单抗巩固治疗效果之间的关系","authors":"Damhuis Ram, Bahce I, Senan S","doi":"10.1016/j.cllc.2024.07.013","DOIUrl":null,"url":null,"abstract":"","PeriodicalId":504941,"journal":{"name":"Clinical Lung Cancer","volume":null,"pages":null},"PeriodicalIF":0.0000,"publicationDate":"2024-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Association between PD-L1 score and the outcomes of consolidation durvalumab in a large nationwide series of patients with stage III NSCLC treated with chemoradiotherapy\",\"authors\":\"Damhuis Ram, Bahce I, Senan S\",\"doi\":\"10.1016/j.cllc.2024.07.013\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"\",\"PeriodicalId\":504941,\"journal\":{\"name\":\"Clinical Lung Cancer\",\"volume\":null,\"pages\":null},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2024-07-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Clinical Lung Cancer\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1016/j.cllc.2024.07.013\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical Lung Cancer","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1016/j.cllc.2024.07.013","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Association between PD-L1 score and the outcomes of consolidation durvalumab in a large nationwide series of patients with stage III NSCLC treated with chemoradiotherapy